- Home
- LION vs VKTX Comparison
LION vs VKTX Comparison
Compare LION & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LION | VKTX |
|---|---|---|
| Founded | 1997 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.0B |
| IPO Year | 2025 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LION | VKTX |
|---|---|---|
| Price | $12.50 | $24.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 21 |
| Target Price | $15.08 | ★ $94.50 |
| AVG Volume (30 Days) | 3.1M | ★ 6.3M |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,631,800,000.00 | N/A |
| Revenue This Year | $27.42 | N/A |
| Revenue Next Year | $2.09 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.14 | $24.94 |
| 52 Week High | $16.70 | $43.15 |
Technical Indicators
Market Signals| Indicator | LION | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 65.99 | 36.13 |
| Support Level | $11.88 | N/A |
| Resistance Level | $12.58 | $35.23 |
| Average True Range (ATR) | 0.47 | 1.40 |
| MACD | 0.21 | -0.18 |
| Stochastic Oscillator | 81.16 | 1.97 |
Price Performance
Historical ComparisonAbout LION Lionsgate Studios Corp.
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.